# Candida auris screening, positivity trends, and patient characteristics at the University of Kentucky between 2021 and 2024

**Authors:** Faith Fursman, Natalie Fitzsimmons, DaNelle Overton, Court Desmond, Kimberly Blanton, Kevin W. Hatton, Rachel Howard, David Olafsson, Sean McTigue, Nicholas Van Sickels, Derek Forster, Takaaki Kobayashi

PMC · DOI: 10.1017/ash.2025.10151 · Antimicrobial Stewardship & Healthcare Epidemiology : ASHE · 2025-10-14

## TL;DR

A screening program for Candida auris at the University of Kentucky found a low positivity rate, with most cases becoming community-acquired over time.

## Contribution

The study demonstrates the shift in Candida auris cases from healthcare-associated to community-onset following a screening program.

## Key findings

- The positivity rate for Candida auris was 0.96%.
- Community-onset cases increased from 8% to 54% after the screening program was implemented.
- No significant differences were found in patient characteristics between colonization and infection cases.

## Abstract

We evaluated a targeted Candida auris screening program, which revealed a 0.96% positivity rate. The proportion of community-onset cases increased from 8% to 54% following implementation. No significant differences in demographic or clinical characteristics were observed between patients with colonization and those with infection.

## Full-text entities

- **Diseases:** infection (MESH:D007239)
- **Species:** Candidozyma auris (species) [taxon 498019], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12538337/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12538337/full.md

## References

10 references — full list in the complete paper: https://tomesphere.com/paper/PMC12538337/full.md

---
Source: https://tomesphere.com/paper/PMC12538337